STHLM3 Validation Study An observational study conducted in [University Medical Center Groningen and the Prostatce Cancer North Netherland Partners] in cooperation with Karolinska Institutet, Stockholm, Sweden

Completed

• Conditions: Prostatecancer; 10038597

• Registration Number: NL-OMON46757
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

Patients with no previous prostate cancer diagnosis who are scheduled for prostate MRI and/or prostate biopsy.

Exclusion Criteria

Patiënt with previous prostate cancer in medical history,

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Main outcome<br /><br>* Number of biopsies</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcome<br /><br>* Number of biopsies with Gleason Score * 7<br /><br>* Number of biopsies with Gleason Score 6<br /><br>* Number of MRIs </p><br>